Boehringer Ingelheim Semintra (telmisartan oral solution) 10 mg/mL
Recall announced June 30, 2023 by Boehringer Ingelheim Animal Health USA Inc, posted by the U.S. Food and Drug Administration (FDA). Reason: Out of specification for pH and precipitation formation. It affects cats. The agency has closed this recall.
- Brands
- Semintra
- Where sold
- Nationwide.
- Last updated
- November 20, 2026
Products included
- Semintra (telmisartan oral solution) 10 mg/mL For oral use in cats only Angiotensin II Receptor Blocker 35 mL NDC 0010-4492-01 UPC 0 12313 44921 6 Marketed by: Boehringer Ingelheim Animal Health USA Inc. Duluth, GA 30096 (UPC 012313449216; Batches: D49253 Exp. Sept. 2023, D67319 Exp. Sept. 2023)
Read the official notice. Always compare the codes on your package with the official notice. It is the final word.
Has your pet used this product and seems unwell? Call your veterinarian or an emergency animal hospital now.
